UNITED STATES
               SECURITIES AND EXCHANGE COMMISSION
                     Washington, D.C.  20549
                          ____________
                           FORM 10-K/A
                        (Amendment No. 1)

        ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 (d) OF
               THE SECURITIES EXCHANGE ACT OF 1934
             For the fiscal year ended June 30, 2004
                  Commission File Number 0-7491
                          ____________
                         MOLEX INCORPORATED
     (Exact name of registrant as specified in its charter)

            Delaware                           36-2369491
(State or other jurisdiction of            (I.R.S.  Employer
 incorporation or organization)           Identification No.)

          2222 Wellington Court, Lisle, Illinois  60532
            (Address of principal executive offices)
Registrant's telephone number, including area code:  (630) 969-4550
                          ____________
  SECURITIES REGISTERED PURSUANT TO SECTION 12 (b) OF THE ACT:
                              None

   SECURITIES REGISTERED PURSUANT TO SECTION 12 (g) OF THE ACT
                  Common Stock, par value $0.05
              Class A Common Stock, par value $0.05
                          ____________
     Indicate by check mark whether the registrant (1) has  filed
all  reports required to be filed by Section 13 or 15 (d) of  the
Securities  Exchange Act of 1934 during the preceding  12  months
(or  for such shorter period that the registrant was required  to
file  such  reports),  and (2) has been subject  to  such  filing
requirements for the past 90 days.   Yes X    No

     Indicate  by  check  mark  whether  the  registrant  is   an
accelerated filer (as defined in Rule 12b-2 of the Act). Yes X  No

     On  June  30, 2004, the following numbers of shares  of  the
Company's common stock were outstanding:

           Common Stock            100,557,441
           Class A Common Stock     88,418,015
           Class B Common Stock         94,255

     The  aggregate market value of the voting shares  (based  on
the closing price of these shares on the National Association  of
Securities Dealers Automated Quotation System on such date)  held
by non-affiliates was approximately $1.84 billion.


               DOCUMENTS INCORPORATED BY REFERENCE

     Portions  of the Proxy Statement for the Annual  Meeting  of
Stockholders, to be held on October 22, 2004 are incorporated  by
reference into Part III of this report.






                        EXPLANATORY NOTE


      Molex Incorporated (the "Company") is filing this Amendment
No. 1 on Form 10-K/A for the fiscal year ended June 30, 2004,  to
amend its disclosures in Item 9A of its annual report on Form 10-
K  filed  on September 10, 2004 (the "Annual Report") in response
to  a  comment  that the Company received from the Staff  of  the
Division  of  Corporation Finance of the Securities and  Exchange
Commission. This Amendment No. 1 on Form 10-K/A amends only  Item
9A  of  the  Annual  Report.  It does not  affect  the  financial
statements and footnotes or other disclosures filed in the Annual
Report.   Except to the extent expressly set forth  herein,  this
Form  10-K/A  continues to speak as of the date of  the  original
Annual  Report  and the Company has not updated  or  amended  the
disclosure contained herein to reflect events that have  occurred
since the filing of the original Annual Report for the year ended
June  30, 2004.  Accordingly, this Form 10-K/A should be read  in
conjunction  with  our  filings  made  with  the  Securities  and
Exchange  Commission  subsequent to the filing  of  the  original
Annual Report, including any amendments to those filings.

                                   2








                             PART II

Item 9A.  Controls and Procedures

      As  of  the  end of the period covered by this report,  the
Company  conducted an evaluation, under the supervision and  with
the   participation  of  the  principal  executive  officer   and
principal financial officer, of the Company's disclosure controls
and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under
the Securities Exchange Act of 1934 (the "Exchange Act")).  Based
on this evaluation, the principal executive officer and principal
financial   officer  concluded  that  the  Company's   disclosure
controls  and procedures are effective to ensure that information
required to be disclosed by the Company in reports that it  files
or  submits  under  the  Exchange  Act  is  recorded,  processed,
summarized  and  reported within the time  periods  specified  in
Securities  and Exchange Commission rules and forms.   Except  as
described  below,  there was no change in the Company's  internal
control  over  financial  reporting  during  the  Company's  most
recently  completed fiscal quarter that has materially  affected,
or  is  reasonably  likely to materially  affect,  the  Company's
internal control over financial reporting.

     During  the  fourth  quarter of  fiscal  2004,  the  Company
implemented  a  new  process to capture and analyze  the  various
financial  data  used  in  the preparation  of  the  consolidated
statement of cash flows.

     During   the  testing  of  the  new  process,  the   Company
discovered  an error in the consolidated statement of cash  flows
for  the year ended June 30, 2003.  The Company's old process was
based  on  a  Hyperion-based calculated  cash  flow  model  which
recorded  the change in the "other asset" account as an investing
activity.    Other   assets   include  intangibles,   third-party
investments,  deferred  taxes,  prepaid  expenses  and  deposits.
Under  the  old  process, the Company manually  reclassified  the
change  in  deferred  taxes  and  prepaid  pension  to  operating
activities.   The Company made a clerical error of $25.4  million
with  respect  to  the manual adjustment for deferred  taxes  and
prepaid  pension in its cash flow statement for  the  year  ended
June 30, 2003.  The Company also determined that other changes in
the  "other  asset" account amounting to $19.2 million  that  had
been   classified  as  investing  activities  should  have   been
classified  as operating activities.  The result of these  errors
was  an  overstatement of cash provided from operating activities
and  an  overstatement of cash used for investing  activities  by
$44.6 million in the consolidated statement of cash flows for the
year ended June 30, 2003.  In the Form 10-K for fiscal 2004, cash
provided  from  operating activities and cash used for  investing
activities  were restated in the consolidated statement  of  cash
flows for the year ended June 30, 2003.

     Similar errors related to the classification of other  asset
accounts  occurred in the Company's fiscal year  ended  June  30,
2002  and the first three quarters of the fiscal year ended  June
30,  2004.  The impact of such classification errors on  reported
cash  provided  from  operating  activities  and  cash  used  for
investing activities during these periods was not material.

     The   Company's  new  cash  flow  reporting  process,  which
identified  the  fiscal  2003  error,  was  designed  to  improve
management's  ability to analyze and review all significant  cash
flow  activity.  The Company also developed a quarterly cash flow
checklist  as  a  further  control  procedure.   To  specifically
address  the  error described above, the Company  added  separate
balance  sheet  accounts  in its Hyperion  reporting  system  for
intangibles,  investments, deferred taxes and  prepaid  pensions.
The   Company  believes  that  the  new  cash  flow  process  and
additional  review procedures will ensure that future errors  are
prevented.

                                  3




                             PART IV

Item 15 Exhibits, Financial Statement Schedules and Reports on
Form 8-K

(a)   2.  Exhibits

     The  exhibits listed on the accompanying Index  to  Exhibits
are filed as part of this Form 10-K/A.


                                   4






                        Molex Incorporated
                        Index of Exhibits

Exhibit
 Number                        Description
- --------                       -----------

  31         Rule 13a-14(a)/15d-14(a) Certifications

               31.1 Section 302 certification by Chief Executive Officer

               31.2 Section 302 certification by Chief Financial Officer


                                       5






                           SIGNATURES

     Pursuant to the requirements of the Securities Exchange  Act
of  1934, the registrant has duly caused this report to be signed
on its behalf by the undersigned thereunto duly authorized.


                                        MOLEX INCORPORATED
                                        _______________________
                                        (Registrant)


Date:  March 21, 2005                   /s/ ROBERT B. MAHONEY
                                        ______________________
                                        Robert B. Mahoney
                                        Acting Chief Financial Officer,
                                        Executive Vice President and
                                        President, Far East South



Date:  March 21, 2005                   /s/ LOUIS A. HECHT
                                        ___________________
                                        Louis A. Hecht
                                        Corporate Secretary and
                                        General Counsel


                                 6